Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02543294 · ClinicalTrials.gov registry record · NA
REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial)
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02543294: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT02543294 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02543294, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if heart function remains normal after stopping heart failure medication in patients who have received chemotherapy.
Primary Outcome
A withdrawal failure is defined as a decrease in the LVEF when cardiac medications are discontinued as determined by echocardiogram to LVEF\<50% or a decrease by 10% from baseline measurement. Maintenance of LVEF is defined as LVEF≥50%. LVEF was assessed at Baseline, Months 2, 4, 6, 12, 18, \& 30.
Interventions
- BEHAVIORAL Symptom Questionnaire
- DEVICE Echocardiograms
- DEVICE Electrocardiogram
- BEHAVIORAL Telephone Follow-Up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-09-10 |
| Est. Completion | 2017-09-10 |
| Phase | NA |
What the finished NCT02543294 record still lists
NCT02543294 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Symptom Questionnaire is the first listed.
NCT02543294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02543294 about?
NCT02543294 is a clinical study titled "REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial)". The goal of this clinical trial is to learn if heart function remains normal after stopping heart failure medication in patients who have received chemotherapy.
What is the current status of trial NCT02543294?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-09-10. Estimated completion is 2017-09-10.
What interventions are being tested in trial NCT02543294?
The interventions under investigation include: Symptom Questionnaire (BEHAVIORAL), Echocardiograms (DEVICE), Electrocardiogram (DEVICE), Telephone Follow-Up (BEHAVIORAL).
Who is sponsoring clinical trial NCT02543294?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02543294's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI